Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult T Cell Leukemia (ATL)”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Active Not RecruitingNCT02732275
What this trial is testing

DS-3201b in Participants With Lymphomas

Who this might be right for
Lymphoma, MalignantNon-hodgkin Lymphoma
Daiichi Sankyo Co., Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT01378871
What this trial is testing

A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

Who this might be right for
Adult T Cell LeukemiaAdult T Cell Lymphoma
Amit Verma 1
Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00355472
What this trial is testing

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Who this might be right for
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00001941
What this trial is testing

Anti-Tac for Treatment of Leukemia

Who this might be right for
HTLV-I InfectionT Cell Leukemia
National Cancer Institute (NCI) 34
Early research (Phase 1)Ended earlyNCT00664677
What this trial is testing

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Who this might be right for
LeukemiasAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)+5 more
Erimos Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00061048
What this trial is testing

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Acute T-Cell Leukemia-Lymphoma
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT01724177
What this trial is testing

Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

Who this might be right for
Adult T-Cell Leukemia-Lymphoma
Celgene 26
Testing effectiveness (Phase 2)Study completedNCT02955589
What this trial is testing

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)

Who this might be right for
Adult T-Cell Lymphoma (ATL)
HUYABIO International, LLC. 23
Early research (Phase 1)Study completedNCT00001249
What this trial is testing

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

Who this might be right for
Leukemia, T-CellLymphoma, T-Cell, Cutaneous
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT01087333
What this trial is testing

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Who this might be right for
Hairy Cell Leukemia (HCL)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkins Lymphoma (NHL)+2 more
National Cancer Institute (NCI) 1,263
Testing effectiveness (Phase 2)Study completedNCT01626664
What this trial is testing

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Who this might be right for
Adult T-cell Leukemia-Lymphoma
Kyowa Kirin, Inc. 71
Not applicableActive Not RecruitingNCT05237245
What this trial is testing

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)

Who this might be right for
Lymphoproliferation Induced by HTLV-1HTLV-1 Adult T-cell Lymphoma / LeukemiaHTLV-1 Infection
Assistance Publique - Hôpitaux de Paris 69
Testing effectiveness (Phase 2)Study completedNCT00019227
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Who this might be right for
LymphomaRadiation Toxicity
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85